A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/09 (2006.01) C07K 7/23 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2189326
The invention provides a method for treating liver cancer in a mammal comprising administering to the mammal an inhibitory effective amount of at least one GnRH-related compound. Pharmaceutical preparations useful for the treatment of liver cancer comprising an inhibitory effective amount of at least one GnRH-related compound and a pharmaceutically acceptable carrier are also provided. A further aspect of the invention provides a method for diagnosing liver cancer by determining the presence of receptors for GnRH on a biological sample.
L'invention concerne un procédé de traitement du cancer du foie chez un mammifère consistant à administrer à un mammifère une dose inhibitrice efficace d'au moins un composé apparenté à la gonadolibérine (GnRH). L'invention permet d'obtenir des préparations pharmaceutiques destinées à être utilisées dans le traitement du cancer du foie et comprenant une dose inhibitrice efficace d'au moins un composé apparenté à la gonadolibérine et d'un excipient pharmaceutiquement acceptable. Un autre aspect de l'invention concerne un procédé permettant d'établir le diagnostic du cancer du foie grâce à la détermination de la présence de récepteurs de la gonadolibérine dans un échantillon biologique.
Habibi Hamid R.
Marks & Clerk
University Technologies International Inc.
LandOfFree
Inhibition of liver cancer by the use of gnrh and gnrh analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of liver cancer by the use of gnrh and gnrh analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of liver cancer by the use of gnrh and gnrh analogs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1344365